Parameter | Breast cancer < 50 yearsa (percentage) | All CBC patients (n = 247) | Previous RT (n = 169) | No RT (n = 78) | Carriers versus non-carriers | |||||
---|---|---|---|---|---|---|---|---|---|---|
 |  | n | Percentage | n | Percentage | n | Percentage | OR for CBC after RT | 95% CI | p |
DDRP mutated | ~10 | 51 | 21 | 41 | 24.3 | 10 | 12.8 | 2.18 | 1.03–4.62 | 0.043 |
CHEK2 | 1–2 | 15 | 6.1 | 13 | 7.7 | 2 | 2.6 | 3.17 | 0.69–14.39 |  |
BRCA1 | ~4–5 | 27 | 11.3 | 20 | 11.8 | 7 | 9 | 1.36 | 0.55–3.37 |  |
BRCA2 | ~0.5–1 | 5 | 2 | 4 | 2.4 | 1 | 1.3 | 1.87 | 0.21–16.98 |  |
ATM truncating | ~1–2 | 4 | 1.6 | 4 | 2.4 | 0 | 0 | - | - |  |
 |  |  |  |  |  | 1b | 1.3 | 1.87 | 0.21–16.98 |  |